Understanding Prosthetic Patch and Stent Infections

Understanding Late Neck Swelling After Carotid Surgery

When a patient presents with late neck swelling following carotid endarterectomy (CEA), it is crucial not to immediately assume it is a seroma. This is because prosthetic patch infections, though occurring in only about 1% of CEAs, often manifest as neck masses or abscesses. Notably, over half of these infections present more than six months after the surgery, frequently accompanied by a draining sinus. This delayed presentation is a key reason why late neck swelling should not be automatically attributed to a benign seroma.

Diagnostic imaging plays a vital role in distinguishing between a seroma and a patch infection. Duplex ultrasound (DUS) is typically the first-line imaging technique. It can reveal signs of infection such as patch corrugation, which may appear up to 11 months before overt clinical infection. If DUS findings suggest infection, further imaging with CT angiography (CTA) or MRI is recommended, especially if surgical re-exploration is considered.

The microbiological profile of these infections also provides insight. Staphylococci and Streptococci are responsible for 90% of cases, with Staphylococcus aureus more common in early infections and Staphylococcus epidermidis in later ones. This distinction aids in guiding empirical antibiotic therapy before culture results are available.

Given the potential severity of patch infections, conservative management is generally not advised for fit patients. The risk of complications such as secondary hemorrhage or tracheal compression due to anastomotic dehiscence or wall necrosis is significant. Therefore, a multidisciplinary approach to treatment, considering the patient's overall health and surgical risk, is essential for effective management.

Rarity of Prosthetic Patch and Stent Infections

Prosthetic patch infections following carotid endarterectomy (CEA) are relatively uncommon, occurring in approximately 1% of cases. These infections can manifest in different ways, with about half presenting within three months post-operation, typically as an abscess or neck mass. The remaining 55% of infections tend to appear after more than six months, often with a draining sinus. Although patch rupture or anastomotic dehiscence leading to pseudoaneurysm formation can occur, this is relatively rare and happens mainly within the first three months post-CEA, with an incidence of 11%.

In terms of causative organisms, staphylococci and streptococci are responsible for 90% of these infections. Staphylococcus aureus is more common in early infections, while Staphylococcus epidermidis tends to predominate in later stages. Despite their rarity, prompt diagnosis and treatment are crucial due to the serious complications that can arise, such as secondary hemorrhage or tracheal compression.

Carotid stent graft infections are even less common, with only nine reported cases. These infections have been associated with organisms like S. aureus, Streptococcus, and Candida. The clinical presentation can include abscesses, neck mass, bleeding, and septic embolization. Given the rarity of these infections, they require careful management, often involving the excision of infected material and autologous reconstruction.

Presentation and Timing of Prosthetic Patch and Stent Infections

Infections following carotid endarterectomy (CEA) are uncommon, occurring in about 1% of cases. Roughly half of these infections appear within the first three months post-operation, often manifesting as an abscess or neck swelling. The remaining 55% of infections typically emerge after six months, with symptoms such as a draining sinus. Within the initial three months, patch rupture or separation at the surgical joint, leading to pseudoaneurysm, is infrequently observed, accounting for 11% of cases.

The primary bacteria involved in these infections are Staphylococci and Streptococci. Staphylococcus aureus is more frequently responsible for early infections, while Staphylococcus epidermidis is often found in infections occurring later. It is crucial for medical teams to determine antibiotic therapy based on possible organisms when culture results are unavailable.

For diagnosis, duplex ultrasound (DUS) serves as the initial imaging method, detecting changes in the patch that could signal infection, sometimes up to 11 months before symptoms become apparent. Further examination with CT angiography (CTA) or MRI is advised if re-exploration is considered necessary.

Diagnosis and Management of Prosthetic Patch and Stent Infections

Prosthetic patch infection is a rare but serious complication, occurring in about 1% of carotid endarterectomies (CEAs). Diagnosis often involves using Duplex Ultrasound Screening (DUS) as the initial approach, which can detect signs such as patch corrugation, deep collections, or pseudoaneurysms. These findings may manifest up to 11 months prior to clear infection symptoms. Should surgical re-exploration be considered, further imaging with CTA or MRI is recommended.

Management of prosthetic patch infections requires a tailored approach. The first step is excising the infected material, followed by reconstruction using autologous tissue, like a vein patch. This is the preferred method due to lower reinfection rates compared to prosthetic options, which are generally avoided.

In terms of microorganism involvement, Staphylococci and Streptococci are responsible for 90% of infections. Early infections often involve Staphylococcus aureus, while later ones are linked to Staphylococcus epidermidis. Antibiotic regimens should be determined with a multidisciplinary team, especially when cultures are unavailable.

The EndoVAC technique offers an alternative for selected high-risk patients or emergencies. This method entails covering the infected area with a stent graft, followed by debridement and vacuum-assisted therapy to promote healing. Long-term antibiotic use is also part of this strategy.

Carotid ligation is reserved for dire situations, taking into account the patient's tolerance during the initial operation. Despite the fact that peri-operative risks are higher than in primary CEA, with mortality at 3.6% and stroke risk at 6.4%, such interventions should be carefully discussed with patients due to potential outcomes.

Scope of Recommendations for Prosthetic Patch and Stent Infections

The European Society for Vascular Surgery (ESVS) provides specific recommendations for managing infections related to prosthetic patches and carotid stents. These recommendations focus on the treatment strategies for patients with confirmed infections. The primary guidance is to excise the infected material and proceed with autologous venous reconstruction. This approach is preferred due to its lower risk of reinfection compared to prosthetic reconstruction, which is not recommended.

In situations where patients are at high risk for surgery or in emergencies with suspected prosthetic patch infections, the guidelines allow for the consideration of a covered stent as part of the EndoVAC technique. This three-stage process includes stent graft relining, debridement, and vacuum-assisted therapy, followed by long-term antibiotic treatment.

The recommendations do not extend to conservative management strategies in fit patients, due to the associated high risks, such as secondary hemorrhage or tracheal compression. They also do not cover detailed diagnostic protocols or specific antibiotic regimens, which should be determined by a multidisciplinary team based on the likely microorganisms involved. The guidelines align closely with those from the Society for Vascular Surgery (SVS) and German-Austrian guidelines, ensuring a consistent approach across different regions.